Our Publishing Partners

Below are details of our Publishing Partners for 2016. We are indebted to their commitment to the African health sector, through their support towards the publication of Africa Health throughout the year.

BD Biosciences is a world leader in bringing innovative diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production and disease management. The BD Biosciences segment is focused on continually advancing the science and applications associated with cellular analysis.

The ExxonMobil Foundation is the U.S. philanthropic arm of Exxon Mobil Corporation. Under the leadership of President Suzanne McCarron, the Foundation aims to have a meaningful impact by focusing on significant challenges in communities where the company operates. In particular, the Foundation invests in three key areas: promoting women as catalysts for development, combatting malaria and other infectious diseases in the developing world and improving math and science education in the United States. In keeping with this mission, the ExxonMobil Foundation is proud to support Africa Health in its effort to educate health professionals across Africa. To learn more about the Foundation, please visitwww.exxonmobil.com/community.

GSK are a science-led global healthcare company. They research and develop a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. They also have a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large research and development centres in the UK, USA, Spain, Belgium, and China. The GSK Pharmaceuticals side of the business develops and makes medicines to treat a broad range of acute and chronic diseases. Our portfolio is made up of both patent-protected and off patent medicines. Their vaccines business is one of the largest in the world, producing paediatric and adult vaccines against a range of infectious diseases. In 2014, they distributed more than 800 million doses to 170 countries, of which over 80% were supplied to developing countries.

HMD is a market leader in the healthcare industry. HMD was founded in 1957 and is a closely held family Corporation. Its markets include Africa, India, USA, Europe, Middle East, and South East Asia. HMD has seven plants in different locations around South Asia and has more than 3500 employees. Their product range includes single use syringes, single use needles, I.V. cannulas, safety I.V. cannulas, surgical blades, scalpels, scalp vein sets, glass syringes, non-reusable (AD) syringes, blood collection tubes, blood collection needle, and blood collection set.

HemoCue is a global leader in a field of diagnostics known as near patient, or point-of-care, testing. In 1982, HemoCue AB, based in Ängelholm, Sweden, introduced the first system making accurate hemoglobin testing possible in near-patient settings. Since then, more than 350,000 HemoCue systems have been sold worldwide. The company also sells point-of-care tests for glucose, urine albumin, HbA1c, total and differential white blood cell count. HemoCue subsidiaries, affiliates, franchises, and third-party distributors generate revenue in more than 130 countries world wide. HemoCue was acquired by Radiometer, a Danaher company, in April 2013. Additional company information is available at www.hemocue.com.

Medicines for Malaria Venture (MMV) is recognized as the leading product development partnership (PDP) in the field of antimalarial drug research and development. It was established as a foundation in 1999 and registered in Switzerland. MMV’s mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs. MMV’s vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease.

Elizabeth Poll T +41 22 799 45 81

Medicines for Malaria Venture | MMV 20, route de Pré-Bois – PO Box 1826 1215 Geneva 15 – Switzerland

Merck & Co., Inc. is a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products, which it markets directly and through its joint ventures. The company operates as Merck Sharp & Dohme (MSD) outside of the U.S. and Canada. Merck is committed to improving health and well-being around the world. From developing new therapies that treat and prevent disease to helping people in need, they are guided by a rich legacy and inspired by a shared vision.